Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Abdullah Al Emran, Ph.D.

Title
Institution
Department
Address

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Emran AA, Fisher DE. Dual Targeting with EZH2 Inhibitor and STING Agonist to Treat Melanoma. J Invest Dermatol. 2022 04; 142(4):1004-1006. PMID: 35131084; PMCID: PMC8957612.
    Citations:    Fields:    Translation:Humans
  2. Alavi S, Emran AA, Tseng HY, Tiffen JC, McGuire HM, Hersey P. Nicotinamide Inhibits T Cell Exhaustion and Increases Differentiation of CD8 Effector T Cells. Cancers (Basel). 2022 Jan 10; 14(2). PMID: 35053490; PMCID: PMC8774026.
    Citations: 2     
  3. Ahmed F, Tseng HY, Ahn A, Gunatilake D, Alavi S, Eccles M, Rizos H, Gallagher SJ, Tiffen JC, Hersey P, Emran AA. Repurposing Melanoma Chemotherapy to Activate Inflammasomes in the Treatment of BRAF/MAPK Inhibitor Resistant Melanoma. J Invest Dermatol. 2022 05; 142(5):1444-1455.e10. PMID: 34695412.
    Citations: 3     Fields:    Translation:HumansAnimals
  4. Punnia-Moorthy G, Hersey P, Emran AA, Tiffen J. Lysine Demethylases: Promising Drug Targets in Melanoma and Other Cancers. Front Genet. 2021; 12:680633. PMID: 34220955.
    Citations: 3     
  5. Huang JC, Emran AA, Endaya JM, McCaughan GW, Gorrell MD, Zhang HE. DPP9: Comprehensive In Silico Analyses of Loss of Function Gene Variants and Associated Gene Expression Signatures in Human Hepatocellular Carcinoma. Cancers (Basel). 2021 Apr 01; 13(7). PMID: 33915844.
    Citations: 3     
  6. Emran AA, Tseng HY, Gunatilake D, Cook SJ, Ahmed F, Wang S, Hersey P, Gallagher SJ, Tiffen JC. A Combination of Epigenetic BET and CDK9 Inhibitors for Treatment of Human Melanoma. J Invest Dermatol. 2021 09; 141(9):2238-2249.e12. PMID: 33781756.
    Citations: 1     Fields:    Translation:HumansAnimalsCells
  7. Emran AA, Gallagher SJ, Tiffen JC, Hersey P. Sex bias of females in survival from cancer and infections. Is X the answer? Br J Cancer. 2021 03; 124(7):1184-1186. PMID: 33469152; PMCID: PMC7813969.
    Citations: 1     Fields:    Translation:HumansCells
  8. Emran AA, Nsengimana J, Punnia-Moorthy G, Schmitz U, Gallagher SJ, Newton-Bishop J, Tiffen JC, Hersey P. Study of the Female Sex Survival Advantage in Melanoma-A Focus on X-Linked Epigenetic Regulators and Immune Responses in Two Cohorts. Cancers (Basel). 2020 Jul 28; 12(8). PMID: 32731355.
    Citations: 8     
  9. Tiffen J, Gallagher SJ, Filipp F, Gunatilake D, Emran AA, Cullinane C, Dutton-Register K, Aoude L, Hayward N, Chatterjee A, Rodger EJ, Eccles MR, Hersey P. EZH2 Cooperates with DNA Methylation to Downregulate Key Tumor Suppressors and IFN Gene Signatures in Melanoma. J Invest Dermatol. 2020 12; 140(12):2442-2454.e5. PMID: 32360600.
    Citations: 18     Fields:    Translation:HumansAnimalsCells
  10. Tseng HY, Dreyer J, Emran AA, Gunatilake D, Pirozyan M, Cullinane C, Dutton-Regester K, Rizos H, Hayward NK, McArthur G, Hersey P, Tiffen J, Gallagher S. Co-targeting bromodomain and extra-terminal proteins and MCL1 induces synergistic cell death in melanoma. Int J Cancer. 2020 10 15; 147(8):2176-2189. PMID: 32249419.
    Citations: 5     Fields:    Translation:HumansAnimalsCells
  11. Madorsky Rowdo FP, Barón A, Gallagher SJ, Hersey P, Emran AA, Von Euw EM, Barrio MM, Mordoh J. Epigenetic inhibitors eliminate senescent melanoma BRAFV600E cells that survive long-term BRAF inhibition. Int J Oncol. 2020 06; 56(6):1429-1441. PMID: 32236593.
    Citations: 4     Fields:    Translation:HumansCells
  12. Pirozyan MR, McGuire HM, Emran AA, Tseng HY, Tiffen JC, Lee JH, Carlino MS, Menzies AM, Long GV, Scolyer RA, Fazekas de St Groth B, Hersey P. Pretreatment Innate Cell Populations and CD4 T Cells in Blood Are Associated With Response to Immune Checkpoint Blockade in Melanoma Patients. Front Immunol. 2020; 11:372. PMID: 32210968.
    Citations: 9     Fields:    Translation:HumansCells
  13. Emran AA, Tseng HY, Coleman MC, Tiffen J, Cook S, McGuire HM, Gallagher S, Feng C, Hersey P. Do innate killing mechanisms activated by inflammasomes have a role in treating melanoma? Pigment Cell Melanoma Res. 2020 09; 33(5):660-670. PMID: 32027447.
    Citations: 4     Fields:    Translation:HumansAnimals
  14. Emran AA, Marzese DM, Menon DR, Hammerlindl H, Ahmed F, Richtig E, Duijf P, Hoon DS, Schaider H. Commonly integrated epigenetic modifications of differentially expressed genes lead to adaptive resistance in cancer. Epigenomics. 2019 05; 11(7):732-737. PMID: 31070054.
    Citations: 2     Fields:    Translation:HumansCells
  15. Emran AA, Chatterjee A, Rodger EJ, Tiffen JC, Gallagher SJ, Eccles MR, Hersey P. Targeting DNA Methylation and EZH2 Activity to Overcome Melanoma Resistance to Immunotherapy. Trends Immunol. 2019 04; 40(4):328-344. PMID: 30853334.
    Citations: 67     Fields:    Translation:HumansCells
  16. Emran AA, Chinna Chowdary BR, Ahmed F, Hammerlindl H, Huefner A, Haass NK, Schuehly W, Schaider H. Magnolol induces cell death through PI3K/Akt-mediated epigenetic modifications boosting treatment of BRAF- and NRAS-mutant melanoma. Cancer Med. 2019 03; 8(3):1186-1196. PMID: 30793515.
    Citations: 6     Fields:    Translation:HumansCells
  17. Bashar M, Ahmed K, Uddin MS, Ahmed F, Emran AA, Chakraborty A. Depression and Quality of Life among Postmenopausal Women in Bangladesh: A Cross-sectional Study. J Menopausal Med. 2017 Dec; 23(3):172-181. PMID: 29354617; PMCID: PMC5770527.
    Citations: 6     
  18. Emran AA, Marzese DM, Menon DR, Stark MS, Torrano J, Hammerlindl H, Zhang G, Brafford P, Salomon MP, Nelson N, Hammerlindl S, Gupta D, Mills GB, Lu Y, Sturm RA, Flaherty K, Hoon DSB, Gabrielli B, Herlyn M, Schaider H. Distinct histone modifications denote early stress-induced drug tolerance in cancer. Oncotarget. 2018 Feb 02; 9(9):8206-8222. PMID: 29492189.
    Citations: 33     Fields:    
  19. Hammerlindl H, Ravindran Menon D, Hammerlindl S, Emran AA, Torrano J, Sproesser K, Thakkar D, Xiao M, Atkinson VG, Gabrielli B, Haass NK, Herlyn M, Krepler C, Schaider H. Acetylsalicylic Acid Governs the Effect of Sorafenib in RAS-Mutant Cancers. Clin Cancer Res. 2018 03 01; 24(5):1090-1102. PMID: 29196297; PMCID: PMC5844814.
    Citations: 9     Fields:    Translation:HumansAnimalsCells
  20. Chowdhury MK, Moniruzzaman M, Emran AA, Mostafa MG, Kuddus RH, Uddin MA. TP53 Codon 72 Polymorphisms and Lung Cancer Risk in the Bangladeshi Population. Asian Pac J Cancer Prev. 2015; 16(8):3493-8. PMID: 25921167.
    Citations: 5     Fields:    Translation:Humans
  21. Oany AR, Emran AA, Jyoti TP. Design of an epitope-based peptide vaccine against spike protein of human coronavirus: an in silico approach. Drug Des Devel Ther. 2014; 8:1139-49. PMID: 25187696.
    Citations: 36     Fields:    Translation:HumansCells
  22. Ahmed K, Emran AA, Jesmin T, Mukti RF, Rahman MZ, Ahmed F. Early detection of lung cancer risk using data mining. Asian Pac J Cancer Prev. 2013; 14(1):595-8. PMID: 23534801.
    Citations: 9     Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Emran's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (123)
Explore
_
Co-Authors (2)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.